JP2019532933A - 鼻腔内系への使用および送達のためのアンモニア酸化微生物 - Google Patents
鼻腔内系への使用および送達のためのアンモニア酸化微生物 Download PDFInfo
- Publication number
- JP2019532933A JP2019532933A JP2019515834A JP2019515834A JP2019532933A JP 2019532933 A JP2019532933 A JP 2019532933A JP 2019515834 A JP2019515834 A JP 2019515834A JP 2019515834 A JP2019515834 A JP 2019515834A JP 2019532933 A JP2019532933 A JP 2019532933A
- Authority
- JP
- Japan
- Prior art keywords
- preparation
- subject
- administered
- aom
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Child & Adolescent Psychology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662397642P | 2016-09-21 | 2016-09-21 | |
| US62/397,642 | 2016-09-21 | ||
| PCT/US2017/052671 WO2018057710A1 (en) | 2016-09-21 | 2017-09-21 | Ammonia oxidizing microorganisms for use and delivery to the intranasal system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019532933A true JP2019532933A (ja) | 2019-11-14 |
| JP2019532933A5 JP2019532933A5 (https=) | 2020-11-12 |
Family
ID=60022194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019515834A Pending JP2019532933A (ja) | 2016-09-21 | 2017-09-21 | 鼻腔内系への使用および送達のためのアンモニア酸化微生物 |
Country Status (14)
| Country | Link |
|---|---|
| US (6) | US20200016216A1 (https=) |
| EP (1) | EP3515464B1 (https=) |
| JP (1) | JP2019532933A (https=) |
| KR (1) | KR20190055159A (https=) |
| CN (1) | CN110191716A (https=) |
| AU (1) | AU2017332347A1 (https=) |
| BR (1) | BR112019005536A2 (https=) |
| CA (1) | CA3037703A1 (https=) |
| IL (1) | IL265508A (https=) |
| MX (1) | MX2019003191A (https=) |
| PH (1) | PH12019500622A1 (https=) |
| RU (1) | RU2019111715A (https=) |
| SG (1) | SG10202109410XA (https=) |
| WO (1) | WO2018057710A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210100224A (ko) * | 2014-04-15 | 2021-08-13 | 에이오바이오미 엘엘씨 | 암모니아-산화 니트로소모나스 유트로파 균주 d23 |
| WO2019018425A1 (en) * | 2017-07-18 | 2019-01-24 | Aobiome Llc | AMMONIA-OXIDIZING MICROORGANISMS FOR INJECTION USE AND ADMINISTRATION |
| WO2019018348A1 (en) * | 2017-07-18 | 2019-01-24 | Aobiome Llc | AMMONIA-OXIDIZING MICROORGANISMS FOR UTILIZATION AND ADMINISTRATION AT THE UROGENITAL SYSTEM |
| US20200206278A1 (en) * | 2017-07-18 | 2020-07-02 | Aobiome Llc | Ammonia oxidizing microorganisms for the treatment of pulmonary hypertension |
| EP3654999A4 (en) * | 2017-07-18 | 2021-03-31 | Aobiome LLC | AMMONIA COXIDIZING MICROORGANISMS FOR THE TREATMENT OF HEADACHE |
| US10883260B2 (en) * | 2018-01-17 | 2021-01-05 | Andrew Lee Reger | Scent barrier and dispenser |
| KR102831159B1 (ko) | 2018-04-16 | 2025-07-07 | 온퀄리티 파마슈티컬스 차이나 리미티드 | 암 치료의 부작용을 예방하거나 치료하기 위한 방법 |
| WO2022147585A1 (en) * | 2020-12-31 | 2022-07-07 | Ntby Moss Llc | Formulations of a prophylactic nasal spray and methods of use and manufacture thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015160911A2 (en) * | 2014-04-15 | 2015-10-22 | Aobiome Llc | Ammonia-oxidizing nitrosomonas eutropha strain d23 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1243390B (it) | 1990-11-22 | 1994-06-10 | Vectorpharma Int | Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione. |
| FR2774674B1 (fr) | 1998-02-10 | 2000-03-24 | Atochem Elf Sa | Procede de preparation d'une solution aqueuse de peroxyde d'hydrogene directement a partir d'hydrogene et d'oxygene et dispositif permettant sa mise en oeuvre |
| KR20030065463A (ko) | 2000-08-11 | 2003-08-06 | 데이비드 알. 휘트록 | 질소 산화물 및 질소 산화물 전구체의 생산을 증가시키기위한 암모니아 산화 박테리아를 포함하는 조성물 및 이를이용하는 방법 |
| US10383900B2 (en) * | 2014-05-22 | 2019-08-20 | Aobiome Llc | Systems and methods for storage and delivery of ammonia oxidizing bacteria |
| CA2949833C (en) | 2014-05-22 | 2024-06-11 | Aobiome Llc | Methods of preparing materials with ammonia oxidizing bacteria and testing materials for ammonia oxidizing bacteria |
| WO2016161285A1 (en) * | 2015-04-02 | 2016-10-06 | Aobiome Llc | Production of nitro-fatty acids and nitro-hydrocarbons by ammonia oxidizing bacteria |
| CN109069878A (zh) | 2015-07-02 | 2018-12-21 | Ao生物医学有限责任公司 | 微生物群系相容性化妆品 |
| WO2017004557A1 (en) * | 2015-07-02 | 2017-01-05 | Aobiome Llc | Ammonia oxidizing bacteria for treatment of acne |
-
2017
- 2017-09-21 BR BR112019005536A patent/BR112019005536A2/pt not_active Application Discontinuation
- 2017-09-21 CA CA3037703A patent/CA3037703A1/en active Pending
- 2017-09-21 KR KR1020197010958A patent/KR20190055159A/ko not_active Ceased
- 2017-09-21 MX MX2019003191A patent/MX2019003191A/es unknown
- 2017-09-21 SG SG10202109410X patent/SG10202109410XA/en unknown
- 2017-09-21 AU AU2017332347A patent/AU2017332347A1/en not_active Abandoned
- 2017-09-21 CN CN201780071609.XA patent/CN110191716A/zh active Pending
- 2017-09-21 EP EP17780585.0A patent/EP3515464B1/en active Active
- 2017-09-21 JP JP2019515834A patent/JP2019532933A/ja active Pending
- 2017-09-21 WO PCT/US2017/052671 patent/WO2018057710A1/en not_active Ceased
- 2017-09-21 RU RU2019111715A patent/RU2019111715A/ru unknown
- 2017-09-21 US US16/335,434 patent/US20200016216A1/en not_active Abandoned
-
2019
- 2019-03-20 IL IL265508A patent/IL265508A/en unknown
- 2019-03-21 PH PH12019500622A patent/PH12019500622A1/en unknown
-
2022
- 2022-07-15 US US17/812,889 patent/US20220347230A1/en not_active Abandoned
-
2023
- 2023-01-26 US US18/160,007 patent/US20230172998A1/en not_active Abandoned
- 2023-08-25 US US18/238,167 patent/US20230398157A1/en not_active Abandoned
-
2025
- 2025-04-10 US US19/175,409 patent/US20250235489A1/en not_active Abandoned
- 2025-11-13 US US19/388,926 patent/US20260069642A1/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015160911A2 (en) * | 2014-04-15 | 2015-10-22 | Aobiome Llc | Ammonia-oxidizing nitrosomonas eutropha strain d23 |
Also Published As
| Publication number | Publication date |
|---|---|
| RU2019111715A (ru) | 2020-10-26 |
| US20230398157A1 (en) | 2023-12-14 |
| US20230172998A1 (en) | 2023-06-08 |
| SG10202109410XA (en) | 2021-10-28 |
| IL265508A (en) | 2019-05-30 |
| CA3037703A1 (en) | 2018-03-29 |
| CN110191716A (zh) | 2019-08-30 |
| KR20190055159A (ko) | 2019-05-22 |
| EP3515464B1 (en) | 2025-11-05 |
| BR112019005536A2 (pt) | 2019-06-25 |
| PH12019500622A1 (en) | 2019-11-11 |
| US20220347230A1 (en) | 2022-11-03 |
| WO2018057710A1 (en) | 2018-03-29 |
| US20260069642A1 (en) | 2026-03-12 |
| EP3515464A1 (en) | 2019-07-31 |
| US20250235489A1 (en) | 2025-07-24 |
| AU2017332347A1 (en) | 2019-04-18 |
| MX2019003191A (es) | 2019-12-05 |
| US20200016216A1 (en) | 2020-01-16 |
| RU2019111715A3 (https=) | 2021-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3515464B1 (en) | Ammonia oxidizing microorganisms for use and delivery to the intranasal system | |
| TW201907935A (zh) | 供使用及遞送至泌尿生殖系統之氨氧化微生物 | |
| US20250152638A1 (en) | Ammonia oxidizing microorganisms for use and delivery to the gastrointestinal system | |
| US20240424032A1 (en) | Ammonia oxidizing microorganisms for dispersing biofilms | |
| US20250205290A1 (en) | Use and delivery of ammonia oxidizing microorganisms for treatment of neurodegenerative disorders | |
| US20250325763A1 (en) | Devices for storage and delivery of nonpathogenic microorganisms | |
| TW201918252A (zh) | 供使用及遞送至呼吸系統之微生物 | |
| US20240226192A1 (en) | Ammonia oxidizing microorganisms for the treatment of headaches | |
| WO2019018425A1 (en) | AMMONIA-OXIDIZING MICROORGANISMS FOR INJECTION USE AND ADMINISTRATION | |
| TW201907932A (zh) | 用於使用及遞送至視覺及聽覺系統之氨氧化微生物 | |
| US20240122994A1 (en) | Ammonia oxidizing microorganisms for use and delivery to the gastrointestinal system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200923 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200923 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210908 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20211207 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20220207 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220308 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20220520 |